Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium zirconium cyclosilicate for maintenance of normokalemia in hyperkalemia
CTR20180170Phase 3Completed
- Sponsor
- ZS Associates
- Start
- Jun 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by ZS Associates. Started Jun 2018; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on CTR20180170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180170.